Reuters logo
BRIEF-Depomed and Slán Medicinal Holdings announce strategic asset transactions
November 7, 2017 / 9:13 PM / 15 days ago

BRIEF-Depomed and Slán Medicinal Holdings announce strategic asset transactions

Nov 7 (Reuters) - Depomed Inc

* Depomed and Slán Medicinal Holdings Ltd announce strategic asset transactions

* Depomed Inc - ‍Slán Medicinal Holdings limited to acquire Lazanda from Depomed​

* Depomed - co to buy from Slán rights to market specialty drug, cosyntropin in united states and divest its Lazanda nasal spray cii to Slán​

* Depomed - intends to seek approval for cosyntropin in u.s., subsequent to approval co, Slán to share in net sales of Cosyntropin for 10-year period​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below